Men with benign prostatic hyperplasia (BPH), have a new, breakthrough treatment option that is less invasive and has fewer complications than other minimally invasive treatments, according to research presented at the Society of Interventional Radiology's (SIR's) Annual Scientific Meeting.

Patients suffering from chronic plantar fasciitis now have a new weapon against this debilitating foot ailment, according to research presented at the Society of Interventional Radiology's Annual Scientific Meeting.

Trice Imaging Inc. and Samsung Electronics announced that the two companies have been nominated for the 20th Global Mobile Awards by the Groupe Speciale Mobile Association (GSMA). Samsung and Trice Imaging are nominated in two categories: the “Best Mobile Innovation for Health” and “Best Use of Mobile in Emergency or Humanitarian Situations” for the project “Mobile Acute Care.”

Claron Technology showcased its NilRead universal zero-footprint diagnostic viewer for mammography applications at the European Congress of Radiology (ECR) in March.

Hitachi Aloka Medical Ltd. announced the release of EggQus — a compact, portable ultrasound bone densitometry system — at the 2015 European Radiology Congress (ECR).

The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the treatment of prostate and bone cancers – reached EUR 157 million (US$ 209 million) in 2014.

Carestream is demonstrating its new Touch Ultrasound System at the American Institute of Ultrasound in Medicine (AIUM) annual meeting, March 21-25.

Treating metastatic melanoma with radiation therapy and two immunotherapies targeting the CTLA4 and PD-1 pathways could elicit an optimal response in more patients, boosting the immune system’s attack on the disease, suggests a new study. The study, from a multidisciplinary team of researchers from Penn’s Abramson Cancer Center, was published in Nature.